BPC-157
A 15-amino-acid fragment related to a gastric protein, and the most-cited peptide in animal models of tendon, gut lining and angiogenesis. Human evidence remains limited.
Benefits of BPC-157
The literature below is why people look this compound up — framed as research, not as a treatment promise.
- 01
Studied for tendon and ligament repair in animal models
- 02
Investigated for gastric and intestinal lining integrity
- 03
Looked at for angiogenesis and blood-flow recovery after injury
- 04
The usual first citation in 'healing stack' research blends
Our recommendation
Why we recommend RegenPep
For a research reference of BPC-157, we recommend RegenPep. The recommendation rests on how the material it supplies is made, tested and documented — nothing else:
Third-party purity and identity testing
Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
Certificate of Analysis available per batch
A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
Supplier transparency
Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
Lab-reported potency consistency
Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
View the BPC-157 pen on RegenPep ↗Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.
How it is thought to work
Proposed mechanisms include nitric-oxide pathway modulation, VEGFR2-linked angiogenesis and growth-hormone-receptor upregulation in tendon fibroblasts. No single receptor story is settled. Almost all of the repair narrative comes from rodent injury models, not large human trials.
Frequently asked
- What is BPC-157?
- BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a sequence in human gastric juice. It is a research compound, not an approved healing medicine.
- What do researchers study BPC-157 for?
- Animal papers report faster recovery in tendon, muscle, gut-ulcer and colitis models. That literature is often overstated online. This profile treats it as preclinical unless a human study is named.
- Is BPC-157 a medicine in Australia?
- BPC-157 is discussed here as a research compound. This site does not present it as a TGA-approved medicine or a treatment. Product links go to RegenPep, an Australian storefront that supplies research peptide pens for laboratory use.
- Which supplier does BPC-157 link to, and why?
- Profiles link to the matching BPC-157 line on RegenPep. We recommend that supplier on manufacturing quality — third-party purity and identity testing, a Certificate of Analysis per batch, documented lot and sourcing information, and lab-reported potency consistency. This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption. Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there.
Peptide Brief · updated 4 September 2026. Research and educational information only.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.